These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 6240359)

  • 1. Hydralazine and lupus nephritis.
    Ihle BU; Whitworth JA; Dowling JP; Kincaid-Smith P
    Clin Nephrol; 1984 Nov; 22(5):230-8. PubMed ID: 6240359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydralazine sensitivity: clinical features, autoantibody changes and HLA-DR phenotype.
    Russell GI; Bing RF; Jones JA; Thurston H; Swales JD
    Q J Med; 1987 Oct; 65(246):845-52. PubMed ID: 3329739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complex glomerulonephritis in hydralazine-induced SLE.
    Shapiro KS; Pinn VW; Harrington JT; Levey AS
    Am J Kidney Dis; 1984 Jan; 3(4):270-4. PubMed ID: 6229178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis.
    Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS
    Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review.
    Dobre M; Wish J; Negrea L
    Ren Fail; 2009; 31(8):745-8. PubMed ID: 19814644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerulonephritis in procainamide induced lupus erythematosus: report of a case and review of the literature.
    Foucar E; Erickson DG; Tung KS
    J Clin Lab Immunol; 1979 Apr; 2(1):79-84. PubMed ID: 95811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydralazine-induced lupus syndrome.
    French WJ
    Ala J Med Sci; 1984 Oct; 21(4):427-30. PubMed ID: 6507805
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug-induced lupus erythematosus.
    Vedove CD; Del Giglio M; Schena D; Girolomoni G
    Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laryngeal manifestations of drug induced lupus.
    Maxwell D; Silver R
    J Rheumatol; 1987 Apr; 14(2):375-7. PubMed ID: 3599009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute immunologic hydralazine reaction. Clinical and serological changes after hydralazine administration to a patient with circulating antinuclear antibodies.
    Alarcón-Segovia D
    Rev Invest Clin; 1972; 24(2):167-74. PubMed ID: 4538312
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-induced systemic lupus erythematosus.
    Stratton MA
    Clin Pharm; 1985; 4(6):657-63. PubMed ID: 2866863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sweet syndrome associated with hydralazine-induced lupus erythematosus.
    Cartee TV; Chen SC
    Cutis; 2012 Mar; 89(3):121-4. PubMed ID: 22530328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapidly progressive nephritis in patients taking hydralazine.
    Mason PD; Lockwood CM
    J Clin Lab Immunol; 1986 Jul; 20(3):151-3. PubMed ID: 3746882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus following prolonged treatment with hydralazine.
    Alkalay I; Bullard JC
    Ann Allergy; 1971 Jan; 29(1):35-6. PubMed ID: 4118529
    [No Abstract]   [Full Text] [Related]  

  • 15. Side-effects in long-term treatment with hydralazine.
    Widgren B; Berglund G; Andersson OK
    Acta Med Scand Suppl; 1986; 714():193-6. PubMed ID: 3472444
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of hypertension and systemic lupus erythematosus.
    Vogl A
    Proc Rudolf Virchow Med Soc City N Y; 1970-1971; 28():157-8. PubMed ID: 5293512
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydralazine, antinuclear antibodies, and the lupus syndrome.
    Mansilla-Tinoco R; Harland SJ; Ryan PJ; Bernstein RM; Dollery CT; Hughes GR; Bulpitt CJ; Morgan A; Jones JM
    Br Med J (Clin Res Ed); 1982 Mar; 284(6320):936-9. PubMed ID: 6802356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydralazine associated pauci-immune glomerulonephritis.
    Suneja M; Baiswar S; Vogelgesang SA
    J Clin Rheumatol; 2014 Mar; 20(2):99-102. PubMed ID: 24561415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced lupus: clinical and serological studies.
    Harmon CE; Portanova JP
    Clin Rheum Dis; 1982 Apr; 8(1):121-35. PubMed ID: 6811188
    [No Abstract]   [Full Text] [Related]  

  • 20. Antinuclear antibodies following hydralazine toxicity.
    Condemi JJ; Moore-Jones D; Vaughan JH; Perry HM
    N Engl J Med; 1967 Mar; 276(9):486-91. PubMed ID: 4959828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.